Evidence map›Paper›PMID 35683916›Full record

ReviewPolymers2022

A Review on Antibacterial Biomaterials in Biomedical Applications: From Materials Perspective to Bioinks Design.

Farnoosh Pahlevanzadeh, Mohsen Setayeshmehr, Hamid Reza Bakhsheshi-Rad, Rahmatollah Emadi, Mahshid Kharaziha, S Ali Poursamar, Ahmad Fauzi Ismail, Safian Sharif, Xiongbiao Chen, Filippo Berto

Open access · goldAbstract readReview
In one paragraph

Review in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Marine drugs · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. 3D Bioprinting for Vascularization.Bioengineering (Basel, Switzerland) · 2023
    Review
  13. Curcumin-Functionalized Graphene Oxide Strongly PreventsPharmaceuticals (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Farnoosh PahlevanzadehDepartment of Materials Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Mohsen SetayeshmehrDepartment of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Hamid Reza Bakhsheshi-RadAdvanced Materials Research Center, Department of Materials Engineering, Najafabad Branch, Islamic Azad University, Najafabad, Iran.
Rahmatollah EmadiDepartment of Materials Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Mahshid KharazihaDepartment of Materials Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.ORCID 0000-0002-5782-8007
S Ali PoursamarBiomaterials, Nanotechnology, and Tissue Engineering Group, Advanced Medical Technology Department, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.ORCID 0000-0002-9824-0947
Ahmad Fauzi IsmailAdvanced Membrane Technology Research Center (AMTEC), Universiti Teknologi Malaysia, Johor Bahru 81310, Johor, Malaysia.
Safian SharifFaculty of Engineering, Universiti Teknologi Malaysia, Johor Bahru 81310, Johor, Malaysia.
Xiongbiao ChenDepartment of Mechanical Engineering, College of Engineering, University of Saskatchewan, Saskatoon, SK S7N 5A9, Canada.ORCID 0000-0002-4716-549X
Filippo BertoDepartment of Mechanical and Industrial Engineering, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Isfahan University of Medical Sciences · IRIsfahan University of Technology · IRUniversity of Technology Malaysia · MYIslamic Azad University of Najafabad · IRNorwegian University of Science and Technology · NOUniversity of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In tissue engineering, three-dimensional (3D) printing is an emerging approach to producing functioning tissue constructs to repair wounds and repair or replace sick tissue/organs. It allows for precise control of materials and other components in the tissue constructs in an automated way, potentially permitting great throughput production. An ink made using one or multiple biomaterials can be 3D printed into tissue constructs by the printing process; though promising in tissue engineering, the printed constructs have also been reported to have the ability to lead to the emergence of unforeseen illnesses and failure due to biomaterial-related infections. Numerous approaches and/or strategies have been developed to combat biomaterial-related infections, and among them, natural biomaterials, surface treatment of biomaterials, and incorporating inorganic agents have been widely employed for the construct fabrication by 3D printing. Despite various attempts to synthesize and/or optimize the inks for 3D printing, the incidence of infection in the implanted tissue constructs remains one of the most significant issues. For the first time, here we present an overview of inks with antibacterial properties for 3D printing, focusing on the principles and strategies to accomplish biomaterials with anti-infective properties, and the synthesis of metallic ion-containing ink, chitosan-containing inks, and other antibacterial inks. Related discussions regarding the mechanics of biofilm formation and antibacterial performance are also presented, along with future perspectives of the importance of developing printable inks.

Indexed as

3D printingantibacterial propertieschitosanmetallic ions

Identifiers

PMID35683916
PMCPMC9182805
OpenAlexW4281741594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.